This page is part of the Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v1.0.0: STU1) based on FHIR v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
: Regulated Authorization for the 75 mg tablet - TTL Representation
Raw ttl | Download
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:RegulatedAuthorization ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "297e405a-b6f9-4273-bc01-ae031efe47f8"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"297e405a-b6f9-4273-bc01-ae031efe47f8\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization "297e405a-b6f9-4273-bc01-ae031efe47f8" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id: authorization75mg (use: OFFICIAL)</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-800a51a2-d81d-49a4-a4eb-f2417d301837.html\">MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837</a></p><p><b>type</b>: Marketing Authorization <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-regulated-authorization-type.html\">Regulated Authorization Type</a>#MarketingAuth)</span></p><p><b>region</b>: European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#FR)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: <a href=\"Organization-d71bf884-90eb-47f9-81b7-fa81ecec7e75.html\">Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75</a> "acme inc"</p></div>"
] ; #
fhir:identifier ( [
fhir:use [ fhir:v "official" ] ;
fhir:system [ fhir:v "http://example.org/sid/product"^^xsd:anyURI ] ;
fhir:value [ fhir:v "authorization75mg" ]
] ) ; #
fhir:subject ( [
fhir:reference [ fhir:v "MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837" ]
] ) ; #
fhir:type [
( fhir:coding [
fhir:system [ fhir:v "http://hl7.org/fhir/regulated-authorization-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "MarketingAuth" ] ;
fhir:display [ fhir:v "Marketing Authorization" ] ] )
] ; #
fhir:region ( [
( fhir:coding [
fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
fhir:code [ fhir:v "FR" ] ] ) ;
fhir:text [ fhir:v "European Union" ]
] ) ; #
fhir:status [
( fhir:coding [
fhir:system [ fhir:v "http://hl7.org/fhir/publication-status"^^xsd:anyURI ] ;
fhir:code [ fhir:v "active" ] ;
fhir:display [ fhir:v "Active" ] ] )
] ; #
fhir:statusDate [ fhir:v "2015-02-07T13:28:17Z"^^xsd:dateTime] ; #
fhir:holder [
fhir:reference [ fhir:v "Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75" ]
] . #